Trypanosomatid essential metabolic pathway: New approaches about heme fate in Trypanosoma cruzi

•An active heme detoxification mechanism is suggested in this work.•For the first time, biliverdin, a heme degradation intermediate, was identified in this parasite.•A putative HO-like protein increases in the presence of heme in T. cruzi. Trypanosoma cruzi, the causal agent of Chagas disease, has a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2014-06, Vol.449 (2), p.216-221
Hauptverfasser: Cupello, M.P., Souza, C.F., Menna-Barreto, R.F., Nogueira, N.P.A., Laranja, G.A.T., Sabino, K.C.C., Coelho, M.G.P., Oliveira, M.M., Paes, M.C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•An active heme detoxification mechanism is suggested in this work.•For the first time, biliverdin, a heme degradation intermediate, was identified in this parasite.•A putative HO-like protein increases in the presence of heme in T. cruzi. Trypanosoma cruzi, the causal agent of Chagas disease, has a complex life cycle and depends on hosts for its nutritional needs. Our group has investigated heme (Fe-protoporphyrin IX) internalization and the effects on parasite growth, following the fate of this porphyrin in the parasite. Here, we show that epimastigotes cultivated with heme yielded the compounds α-meso-hydroxyheme, verdoheme and biliverdin (as determined by HPLC), suggesting an active heme degradation pathway in this parasite. Furthermore, through immunoprecipitation and immunoblotting assays of epimastigote extracts, we observed recognition by an antibody against mammalian HO-1. We also detected the localization of the HO-1-like protein in the parasite using immunocytochemistry, with antibody staining primarily in the cytoplasm. Although HO has not been described in the parasite’s genome, our results offer new insights into heme metabolism in T. cruzi, revealing potential future therapeutic targets.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2014.05.004